Related references
Note: Only part of the references are listed.Outcome of Allogeneic Hematopoietic Cell Transplantation from HLA-Identical Siblings for Severe Aplastic Anemia in Patients Over 40 Years of Age
Dario Sangiolo et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Long-term recovery after hematopoietic cell transplantation: predictors of quality-of-life concerns
F. Lennie Wong et al.
BLOOD (2010)
Implications of CD34+cell dose on clinical and haematological outcome of allo-SCT for acquired aplastic anaemia
M. S. Islam et al.
BONE MARROW TRANSPLANTATION (2010)
Is it time for a change? The case for early application of unrelated allo-SCT for severe aplastic anemia
G. Meyers et al.
BONE MARROW TRANSPLANTATION (2010)
Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors
Vikas Gupta et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA working party
Andrea Bacigalupo et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Effect of Age on Outcome of Reduced-Intensity Hematopoietic Cell Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission or With Myelodysplastic Syndrome
Brian L. McClune et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Allogeneic Hematopoietic Stem-Cell Transplantation for Patients 50 Years or Older With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia
ZiYi Lim et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Prior immunosuppressive therapy with antithymocyte globulin increases the risk of EBV-related lymphoproliferative disorder following allo-SCT for acquired aplastic anaemia
H. C. E. Buyck et al.
BONE MARROW TRANSPLANTATION (2009)
Guidelines for the diagnosis and management of aplastic anaemia
Judith C. W. Marsh et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA
Mark Lawler et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Improved outcome of patients older than 30 years receiving HLA-identical sibling hematopoietic stem cell transplantation for severe acquired aplastic anemia using fludarabine-based conditioning: a comparison with conventional conditioning regimen
Sebastien Maury et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Allogeneic Hematopoietic Stem-Cell Transplantation for Sickle Cell Disease.
Matthew M. Hsieh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Increasing mixed chimerism and the risk of graft loss in children undergoing allogeneic hematopoietic stem cell transplantation for non-malignant disorders
E. Ozyurek et al.
BONE MARROW TRANSPLANTATION (2008)
Graft-versus-host disease following marrow transplantation for aplastic anemia: different impact of two GVHD prevention strategies
D. Siegal et al.
BONE MARROW TRANSPLANTATION (2008)
Prospective multicenter trial comparing repeated immunosuppressive therapy with stem-cell transplantation from an alternative donor as second-line treatment for children with severe and very severe aplastic anemia
Yoshiyuki Kosaka et al.
BLOOD (2008)
Recent improvement in outcome of unrelated donor transplantation for aplastic anemia
R. Viollier et al.
BONE MARROW TRANSPLANTATION (2008)
Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia
Hubert Schrezenmeier et al.
BLOOD (2007)
Delayed attainment of full donor chimaerism following alemtuzumab-based reduced-intensity conditioning haematopoeitic stem cell transplantation for acute myeloid leukaemia and myelodysplastic syndromes is associated with improved outcomes
Zi Yi Lim et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens
Richard E. Champlin et al.
BLOOD (2007)
The influence of cyclosporin alone, or cyclosporin and methotrexate, on the incidence of mixed haematopoietic chimaerism following allogeneic sibling bone marrow transplantation for severe aplastic anaemia
S. McCann et al.
BONE MARROW TRANSPLANTATION (2007)
Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation
Anna Locasciulli et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2007)
Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia
Alana A. Kennedy-Nasser et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Outcomes of alemtuzumab-based reduced intensity conditioning stem cell transplantation using unrelated donors for myelodysplastic syndromes
Zi Yi Lim et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy
H. Joachim Deeg et al.
BLOOD (2006)
Fludarabine, cyclophosphamide and horse antithymocyte globulin conditioning regimen for allogeneic peripheral blood stem cell transplantation performed in non-HEPA filter rooms for multiply transfused patients with severe aplastic anemia
R Kumar et al.
BONE MARROW TRANSPLANTATION (2006)
Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia:: a report from the EBMT-SAA Working Party
A Bacigalupo et al.
BONE MARROW TRANSPLANTATION (2005)
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
ML Sorror et al.
BLOOD (2005)
Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long-term follow-up
C Kahl et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Re: Twenty-year follow-up in patients with aplastic anemia given marrow grafts from HLA-identical siblings and randomized to receive methotrexate/cyclosporine or methotrexate alone for prevention of graft-versus-host disease
ML Sorror et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Marrow transplants from matched unrelated donors for aplastic anaemia using alemtuzumab, fludarabine and cyclophosphamide based conditioning
V Gupta et al.
BONE MARROW TRANSPLANTATION (2005)
Long-term outcome after bone marrow transplantation for severe aplastic anemia
L Ades et al.
BLOOD (2004)
Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine, busulphan, and alemtuzumab (FBC) conditioning
AYL Ho et al.
BLOOD (2004)
Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia
V Gupta et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2004)
Pharmacokinetics of alemtuzumab used for in vivo and in vitro T-cell depletion in allogeneic transplantations: relevance for early adoptive immunotherapy and infectious complications
EC Morris et al.
BLOOD (2003)
Campath-1G causes rapid depletion of circulating host dendritic cells (DCs) before allogeneic transplantation but does not delay donor DC reconstitution
P Klangsinsirikul et al.
BLOOD (2002)
The effect of treatment with Campath-1H in patients with autoimmune cytopenias
F Willis et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: The experience in four centers
R Storb et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2001)
Pharmacokinetics of CAMPATH-1H in BMT patients
P Rebello et al.
CYTOTHERAPY (2001)
Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: Recommendations from a Workshop at the 2001 Tandem Meetings
JH Antin et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2001)
Share Paper
